Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery

Clinical trial NCT00404014 · COMPLETED

Trial details

NCT number: NCT00404014
Sponsor: Allon Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2006-08-01
Primary completion: 2008-06-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.